$60.94 0.12 (+0.20%)
2/13/2012 4:02 PM

Medco Health Solutions, Inc. (NYSE:MHS)

CAPS Rating: 5 out of 5

Provides sophisticated traditional and specialty prescription drug benefit programs and services for clients, members of client-funded benefit plans and individual patients.

Recs

2
Player Avatar ikkyu2 (99.06) Submitted: 1/27/2009 3:14:26 PM : Outperform Start Price: $44.37 MHS Score: -25.14

I work with these companies daily in my day job as a practicing doc.In terms of market share, responsiveness to patients and physicians, and back end, I am beginning to feel strongly that Medco is best of breed.The major risk, I think, is regulatory risk - the current administration may decide to alter the face of American medicine, record-keeping, and/or prescription drug benefits in a way that doesn't benefit MHS.I am not the decider, but I think I tend to doubt this will come to pass. If anything, I suspect Medco's model will be a basis for the shape of drug dispensing to come, and so they'll probably be able to fit into whatever the new administration has in mind.

Report this Post Add Comment

Featured Broker Partners


Advertisement